Jobs · Analyst · Washington

Principal Scientist, CDx IHC Development

SystImmune · Redmond, WA · 1 mo ago
On-siteAnalyst$130k–$160k/yrFull-time

About the Company

SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications, alongside a robust preclinical pipeline of potential cancer therapeutics in the discovery and IND-enabling stages.

About the Role

We are seeking a Principal Scientist to provide technical leadership for the development of immunohistochemistry (IHC) companion diagnostics (CDx) supporting oncology drug programs. This individual will serve as a subject matter expert responsible for CDx assay strategy, analytical validation, and clinical implementation from early feasibility through regulatory submission and commercialization readiness. This is a hands-on scientific leadership role requiring strong collaboration with pathology, translational science, regulatory, clinical development, and external diagnostic partners to ensure successful CDx execution aligned with therapeutic timelines. This position is full-time onsite at our Redmond, WA location.

Responsibilities

  • CDx IHC Kit Development & Strategy
    • Lead development of IHC-based CDx assays and kits from early feasibility through IVD readiness
    • Define assay design, platform selection, and development strategy aligned with CDx regulatory expectations
    • Oversee antibody selection, assay optimization, and standardization across platforms (e.g., Ventana, Dako, Leica)
    • Guide development of scoring algorithms, cut-offs, and interpretation frameworks with pathology leadership
  • Analytical Validation & Design Control
    • Lead analytical validation strategy and execution for CDx IHC assays, including sensitivity, specificity, precision, accuracy, and robustness
    • Ensure validation activities meet regulatory expectations and are conducted under design control
    • Oversee preparation and approval of validation protocols, reports, and technical documentation
    • Ensure traceability, risk management, and documentation in compliance with QSR 820 and ISO 13485
  • Clinical & CDx Implementation
    • Provide oversight for implementation of CDx IHC assays in clinical trials and central laboratories
    • Ensure assay consistency, pathologist alignment, and scoring harmonization across sites
    • Support biomarker strategy, sample plans, and clinical cut-off justification
  • Regulatory & Quality
    • Partner with Regulatory Affairs and QA to support CDx regulatory strategy and submissions (e.g., IND/IDE, PMA/IVD)
    • Ensure compliance with global regulatory requirements (FDA, NMPA, IVDR)
    • Support bridging strategies from RUO/LDT to IVD CDx and contribute to regulatory interactions
    • Drive alignment with QMS, including design controls, change control, and audit readiness
  • Cross-Functional Leadership
    • Act as subject matter expert for CDx IHC development across internal and external stakeholders
    • Lead collaborations with CROs, central labs, and IVD partners
    • Mentor team members and contribute to building CDx development capabilities

Requirements

  • PhD in Pathology, Immunology, Molecular Biology, or related life science field
  • 8–12+ years of industry experience in CDx, IVD, or biomarker assay development
  • Proven experience leading IHC assay development and analytical validation
  • Strong knowledge of design controls and QMS (21 CFR Part 820, ISO 13485)
  • Experience supporting clinical trials and CDx regulatory submissions
  • Strong understanding of IHC scoring methods (TPS, CPS, H-score)
  • Experience working in oncology biomarker development environments

Preferred Qualifications

  • Experience with approved or late-stage CDx programs
  • Background in oncology biomarkers (e.g., NSCLC, GI cancers)
  • Experience interacting with health authorities (FDA, NMPA, EU)

Pay

The expected base salary range for this position is $130,000 - $160,000 annually. Actual compensation will be based on a variety of factors, including but not limited to a candidate’s level, qualifications, experience, and skills.

Benefits

  • 100% paid employee premiums for medical, dental, and vision coverage
  • Short-term and long-term disability insurance
  • 401(k) plan with a 50% company match of up to 3% and a vesting schedule of 5 years
  • 15 PTO days per year, plus sick leave and 11 paid holidays

Similar jobs